Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Reply: To PMID 22504829.

Curtis JR.

Arthritis Care Res (Hoboken). 2014 Aug;66(8):1271-2. doi: 10.1002/acr.22354. No abstract available.

2.

Editor's note.

Hannan MT.

Arthritis Care Res (Hoboken). 2014 Aug;66(8):1272. doi: 10.1002/acr.22353. No abstract available.

3.

Who decides if research will be published, authors or sponsors? Comment on the article by Curtis et al.

Yazici Y.

Arthritis Care Res (Hoboken). 2014 Aug;66(8):1270-1. doi: 10.1002/acr.22356. No abstract available.

4.

Reply: To PMID 25371395.

Gregersen PK, Oswald M, Curran M, Carulli J; BATTER-UP Consortium.

Arthritis Rheumatol. 2015 May;67(8):2277. doi: 10.1002/art.39191. No abstract available.

5.

Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy.

Curtis JR, John A, Baser O.

Arthritis Care Res (Hoboken). 2012 Sep;64(9):1282-91. doi: 10.1002/acr.21693.

6.

[Revised recommendations of the Deutsche Gesellschaft für Rheumatologie on therapy with tumor necrosis factor-inhibiting active substances on inflammatory diseases].

Manger B; Kommission Pharmkotherapie, Deutsche Gesellschaft für Rheumatologie.

Z Rheumatol. 2002 Dec;61(6):694-7. Review. German. No abstract available.

PMID:
12491133
7.

Reply: To PMID 22886739.

Simard JF, Neovius M, Askling J.

Arthritis Rheum. 2013 Jun;65(6):1671-2. doi: 10.1002/art.37929. No abstract available.

8.

Dr. Keystone, et al, reply.

[No authors listed]

J Rheumatol. 2013 May;40(5):732-3. No abstract available.

PMID:
23767071
9.

The evolving use of tumor necrosis factor inhibitors in rheumatoid arthritis.

Kavanaugh A, Cohen S, Cush JJ.

J Rheumatol. 2004 Oct;31(10):1881-4. No abstract available.

PMID:
15468347
10.

[Effectiveness and safety of the treatment with tumour necrosis factor alpha antagonists in rheumatoid arthritis patients].

Arenere Mendoza M, Navarro Aznárez H, Rabanaque Hernández MJ, Manero Ruiz FJ.

Med Clin (Barc). 2005 Jun 4;125(1):35-6. Spanish. No abstract available.

PMID:
15960943
11.

Drug treatments for rheumatoid arthritis: looking backwards to move forwards.

Miossec P.

BMJ. 2015 Mar 13;350:h1192. doi: 10.1136/bmj.h1192. No abstract available.

PMID:
25769296
12.

[Rheumatoid arthritis: determination of the current status].

Michel BA.

Z Rheumatol. 2001 Oct;60(5):307-8. German. No abstract available.

PMID:
11759229
13.

Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade.

Redlich K, Schett G, Steiner G, Hayer S, Wagner EF, Smolen JS.

Arthritis Rheum. 2003 Dec;48(12):3308-19. Review. No abstract available.

14.

[TNF-alpha blocker in rheumatoid arthritis. Who should be treated with the new substances?].

[No authors listed]

MMW Fortschr Med. 2000 Nov 2;142(44):6. German. No abstract available.

PMID:
11107796
15.

TNF alpha blockade in rheumatoid arthritis--time for caution or enthusiasm?

Hamilton JD, Wilson HE, Madhok R, McInnes IB, Capell HA.

Scott Med J. 2001 Jun;46(3):67-70. Review. No abstract available.

PMID:
11501322
16.

Effects of tumor necrosis factor-alpha inhibitors on lung lesions with rheumatoid arthritis.

Inoue K, Takano H, Yanagisawa R, Yoshikawa T.

Chest. 2003 Jul;124(1):413-4; author reply 414. No abstract available.

PMID:
12853558
17.

Is there a pharmacoeconomic argument supporting the use of tumor necrosis factor inhibitors in early rheumatoid arthritis?

Kavanaugh A.

Nat Clin Pract Rheumatol. 2006 Jul;2(7):346-7. Review. No abstract available.

PMID:
16932716
18.

Active tuberculosis in a patient with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitor.

Fuchs I, Abu-Shakra M, Gelfer E, Smoliakov A, Ben-Haroch D, Horowitz J, Avnon LS.

Isr Med Assoc J. 2010 Sep;12(9):579-81. No abstract available.

19.

Access to disease modifying treatments for rheumatoid arthritis patients.

Furst DE, Breedveld FC, Burmester GR, Crofford L, Emery P, Feldman M, Kalden JR, Kavanaugh A, Keystone E, Lipsky PE, Maini RN, Moreland L, Smolen JS, Van De Putte L, Vischer T, Weinblatt M, Weissman M.

Ann Rheum Dis. 1999 Nov;58 Suppl 1:I129-30. Review. No abstract available.

20.

[TNF-alpha antagonists in therapy of rheumatoid arthritis].

Gross WL, Gause A.

Z Rheumatol. 2003 Jun;62(3):217. German. No abstract available.

PMID:
12931691

Supplemental Content

Support Center